November 5, 2010
9:00 A.M. - 6:00 P.M.
UC Davis School of Law
Ongoing improvements in DNA sequencing technology and the increasing availability of bio-banked materials are converging to create advanced personalized medicine diagnostics and treatments that offer the promise of improved outcomes and lower healthcare costs. Fenwick & West and UC Davis School of Law will host a panel of distinguished experts to discuss an array of issues and challenges in the emerging field of personalized medicine. Symposium topics will focus on issues and challenges arising from recent developments that call into question the scope of patent protection available to support investment in this nascent industry as well as issues regarding ownership and licensing of related technology and information; the potential impact of direct to health care consumers offers of genetic tests and other personalized medicine services; and the entrepreneurial environment for personalized medicine in the evolving health care economy. Professionals, entrepreneurs, executives and students in law, medicine, management and other related fields are invited to attend this important symposium to garner knowledge that will synthesize current developments and anticipate future directions along the road to translating the promise of personalized medicine into an emerging, new reality.
MCLE credits available
About the Fenwick & West TESLaw Lecture Series
The TESLaw Lecture Series, sponsored by Fenwick & West, is a five-year program of annual symposiums focused on providing practitioners, academics, and students with the knowledge base to successfully address the challenges that are inherent to the computing, digital communications, social media, "clean" technology, and life sciences and biotechnology markets of the 21st century.
Fenwick & West LLP
Established in the heart of Silicon Valley in 1972, Fenwick & West provides comprehensive legal services to technology and life-sciences clients of national and international prominence. A full-service law firm, Fenwick & West has leading practices in mergers and acquisitions, public securities offerings, venture capital financing, intellectual property prosecution and counseling, intellectual property litigation, securities litigation, tax planning, and tax litigation. More than 275 attorneys work with a wide range of clients, from start-ups to FORTUNE 50 companies, from the firm's offices in Mountain View, San Francisco, Seattle, and Boise.